Depression Treatment in Manhattan, NYC
Depression is one of the most common and most undertreated conditions in mental health care. For many people, it also proves stubbornly resistant to the treatments they've been offered. At InnerMost, we specialize in evidence-based depression treatment in Manhattan that goes further than conventional antidepressants and talk therapy alone. Our integrated approach combines ketamine therapy, Spravato (esketamine), and licensed psychotherapy to address depression at its root, offering new pathways for people who haven't found lasting relief elsewhere.
Understanding Depression
Depression is more than sadness. It is a complex neurobiological condition that affects how you think, feel, sleep, relate to others, and move through the world. For some people it arrives as a single episode, triggered by loss or circumstance. For others it is chronic and recurring, woven into the fabric of daily life for years or decades. And for a significant subset of people, it proves resistant to the treatments most commonly prescribed.
Major depressive disorder (MDD) affects an estimated 21 million adults in the United States. Of those who seek treatment, roughly 30 to 40 percent do not achieve adequate relief from their first antidepressant. For those who have tried two or more medications without meaningful improvement, the clinical term is treatment-resistant depression (TRD), and it represents one of the most challenging and consequential conditions in psychiatry.
At InnerMost, we work with people across the full spectrum of depression, from those experiencing a first episode and looking for a more integrated approach, to those who have been living with treatment-resistant depression for years and are ready to try something different. We believe that the right combination of medicine, therapeutic support, and integration can open doors that have felt permanently closed.
- Major depressive disorder affects an estimated 21 million adults in the United States.
- Up to 30 to 40 percent of people with depression do not respond adequately to their first antidepressant.
- Ketamine and Spravato work through an entirely different mechanism than conventional antidepressants, offering new hope for people with treatment-resistant depression.
A Different Approach to Depression Treatment
Most depression treatment in Manhattan follows a familiar path: a medication consultation, a prescription for an SSRI or SNRI, and a referral to a therapist. For some people, that is enough. For many others, it is not. Conventional antidepressants can take four to six weeks to produce results, and even then, they leave a substantial portion of patients without adequate relief.
At InnerMost, we offer something different: an integrated model that combines the rapid neurological action of ketamine and Spravato with the therapeutic depth of licensed psychotherapy. Rather than treating medication and therapy as separate tracks, we bring them together under one roof, ensuring that each element of your care reinforces the others.
Our approach is built on a core belief: medicine works best when it is paired with skilled therapeutic support. The window of neuroplasticity that ketamine and Spravato create is a genuine opportunity for change, but only if it is met with intentional integration. That is what we provide.
01
Why ketamine and Spravato for depression?
Unlike SSRIs and SNRIs, which work by modulating serotonin over weeks, ketamine and Spravato target the brain’s glutamate system directly. They promote rapid neuroplasticity, the formation of new synaptic connections in regions that depression erodes over time, and can reduce depressive symptoms within hours to days of the first session. For people with treatment-resistant depression, that speed and mechanism represent a meaningful clinical breakthrough.
02
Why psychotherapy alongside it?
Ketamine and Spravato open a window. Psychotherapy is how you walk through it. The heightened neuroplasticity these treatments create makes therapeutic work more accessible and more effective, and dedicated integration sessions after each dosing session are where the benefits become lasting change. At InnerMost, psychotherapy is not an optional complement to our clinical treatments. It is built into every pathway we offer.
Depression Treatments at InnerMost
We offer multiple evidence-based treatment options for depression, each suited to different clinical profiles and patient goals. Your InnerMost care team will help you determine the right fit during your initial consultation.
01
Ketamine Therapy
InnerMost offers ketamine therapy for depression in Manhattan through three formats: Ketamine Infusion With Integration (KIWI), Ketamine Infusion Therapy (KIT), and Ketamine-Assisted Psychotherapy (KAP). All three formats include medical supervision and access to our licensed clinical team. KIWI and KAP include preparation and integration sessions with an InnerMost therapist built into the treatment pathway. Ketamine therapy is particularly well-suited for people with moderate to severe depression, including treatment-resistant depression, who are seeking rapid relief and the depth of a fully integrated therapeutic experience.
02
Spravato® (Esketamine)
Spravato is the only FDA-approved intranasal ketamine therapy for treatment-resistant depression and major depressive disorder with acute suicidal ideation or behavior. It is covered by most major insurance plans, including Aetna, Cigna, UnitedHealthcare, Empire BlueCross, Medicare, and Fidelis, making it one of the most financially accessible advanced depression treatments in Manhattan. At InnerMost, Spravato is offered through three pathways, each with varying levels of psychotherapy integration, and all administered under clinical supervision in our private treatment rooms.
03
Psychotherapy
For patients who are not yet ready for ketamine or Spravato, or who want to begin with a strong therapeutic foundation, InnerMost offers individual psychotherapy with licensed therapists trained in IFS, AEDP, and Gestalt psychology. These evidence-based modalities are particularly effective for depression, addressing not just symptoms but the underlying emotional patterns, relational dynamics, and self-critical beliefs that sustain depressive cycles. Psychotherapy is also the essential ongoing support for patients engaged in ketamine or Spravato treatment, where integration work between sessions is where the real change happens.
Who We Can Help
We work with adults in Manhattan and across New York City who are navigating depression in all its forms. Many of our patients have tried other treatments, sometimes for years, without finding lasting relief. If that describes your experience, you are exactly who we are here to serve.
- People with major depressive disorder (MDD) seeking a more integrated, effective approach to treatment
- Individuals with treatment-resistant depression (TRD) who have not responded to two or more antidepressants
- People experiencing a depressive episode following a major life event, loss, or transition
- Those with MDD and acute suicidal ideation or behavior, for whom Spravato is specifically FDA-approved
- Patients already in therapy or on medication who want to augment their care with ketamine or Spravato
- People new to treatment who want to start with a fully integrated, evidence-based approach from the outset
Depression rarely travels alone. Many of the people we work with are also navigating conditions that commonly co-occur with depression, including anxiety disorders, trauma and PTSD, suicidal ideation, substance use disorder, and the psychological weight of chronic illness. Our team is experienced in working with complex, co-occurring presentations, and our integrated model of care is well-suited to address more than one thing at once
- Anxiety Disorders
- Trauma & PTSD
- Suicidal Ideation
- Substance Use Disorder
- Chronic Illness
How InnerMost's Approach to Depression Works
Our integrated depression treatment model operates on multiple levels simultaneously: neurological, psychological, and relational. Here is what the research and our clinical experience show:
Rapid symptom relief.
Ketamine and Spravato can reduce depressive symptoms within hours to days of the first session. For people who have spent months or years waiting for antidepressants to work or cycling through medications that don’t, this speed is significant and, for many, genuinely life-changing. Both treatments work through the glutamate system, producing neurological changes that conventional antidepressants cannot.
Neurological restoration.
Chronic depression erodes synaptic connections in the prefrontal cortex, hippocampus, and other regions central to mood, cognition, and emotional regulation. Ketamine and Spravato promote neuroplasticity: the regrowth of these connections, creating a window during which the brain is more receptive to therapeutic input and behavioral change. This is the neurological foundation of our integrated model.
Psychological depth.
Depression is not only a brain disease. It is also a pattern of relating to oneself and the world, shaped by experience, loss, and belief. Psychotherapy at InnerMost addresses these patterns directly, using IFS, AEDP, and Gestalt approaches to work with the emotional and relational roots of depression, not just its symptoms. When combined with ketamine or Spravato, this depth of therapeutic work becomes more accessible and more effective.
Sustained change through integration.
The neuroplasticity window opened by ketamine or Spravato is time-limited. Integration therapy, the dedicated sessions with your therapist in the days following each dosing session, is how you make use of it. This is where insights are processed, new patterns are consolidated, and the relief produced by treatment becomes something that lasts. Many of our patients describe feeling like something that had been stuck for years has finally started to move, and integration work is what helps that movement continue.
Treatment-resistant depression: a new path forward.
For people with treatment-resistant depression, InnerMost’s model offers a clinically meaningful alternative to cycling through additional antidepressants. Both ketamine and Spravato have demonstrated efficacy in patients who have not responded to multiple prior treatments. Our integrated approach maximizes the benefit of these interventions by surrounding them with the therapeutic support that helps relief last.
What to Expect: Your Depression Treatment Journey at InnerMost
Every patient who comes to InnerMost for depression treatment has a different history and a different set of needs. Here is how the process typically unfolds:
01
Initial Consultation
You’ll begin with a 1-hour Medical Consultation and a 50-minute Therapy Consultation, typically both via telehealth for your convenience. These sessions cover a comprehensive medical, psychiatric, and psychological assessment to understand your history with depression, what treatments you’ve tried, and what is happening now. Together, your clinical team and you will determine whether ketamine, Spravato, or psychotherapy, or a combination, is the right starting point.
02
Preparation
For patients beginning ketamine or Spravato therapy, a preparation session with a licensed therapist is your next step. This is an opportunity to set intentions, build safety, and lay the psychological groundwork for your first dosing session. We recommend at least one preparation session, with additional sessions available in the week leading up to your initial treatment.
03
Treatment Sessions
Ketamine infusion sessions last 90 to 120 minutes in a private, serene treatment room. Spravato sessions last approximately 120 minutes, including monitoring and recovery time. In both cases, vital signs are monitored throughout, and your clinical team is present to ensure your safety and comfort. Depending on your treatment pathway, an InnerMost therapist may be present before and after administration to help you navigate what arises.
04
Integration
Within a few days of each dosing session, you’ll meet with your therapist for a dedicated integration session. This is where the neuroplasticity window is put to work: processing insights, shifting patterns, and translating what happened in the session into your daily life. Integration is not a debrief. It is a core part of the treatment, and it is what distinguishes InnerMost’s approach from providers who administer ketamine and send patients home.
05
Ongoing Care
A standard course of ketamine infusions for depression is typically six sessions over three to six weeks, followed by optional maintenance. Spravato is typically administered twice weekly for the first four weeks, then weekly or biweekly for maintenance. Your InnerMost team will review your progress throughout and adjust your plan as needed. Ongoing psychotherapy between and after treatment sessions is strongly encouraged and central to sustaining the gains you make.
A Space Designed for Your Healing
Depression can make the world feel gray and contracted. The environment in which you receive treatment matters. Our Manhattan center at 137 East 25th Street, 11th Floor, in the Gramercy neighborhood was intentionally designed to support the nervous system: calming materials, thoughtful layout, and private treatment rooms that feel nothing like a clinical waiting room.
Set and setting matter in psychedelic-assisted therapy, and they matter in all forms of treatment we offer. When you arrive at InnerMost, the space itself is part of the care.
Our center is easily accessible from Midtown, Flatiron, Gramercy, Chelsea, and the East Village. Telehealth consultations are also available for New York residents.
Pricing & Insurance for Depression Treatment in Manhattan
We believe financial considerations shouldn’t stand between you and effective depression treatment. Here’s what you need to know:
Spravato®: covered by most insurance.
Spravato is FDA-approved and covered by most major insurance plans, including Aetna, Cigna, UnitedHealthcare, Empire BlueCross, Medicare, and Fidelis. For eligible patients with treatment-resistant depression or MDD with suicidal ideation, it is the most cost-accessible advanced treatment option we offer. Our team will work with you from day one to verify your benefits and navigate the process.
IV ketamine: not typically covered by insurance.
Most insurance plans do not cover IV ketamine directly. However, portions of your care, including the medical consultation and psychotherapy sessions, may be eligible for partial reimbursement. Our team can provide documentation to support insurance claims and help you explore FSA and HSA eligibility.
Psychotherapy: coverage varies.
Integration and preparatory therapy sessions may or may not be covered depending on your plan. We’ll work with you to understand your options. Please reach out to our team for current pricing and to discuss what may be available under your plan.
Frequently Asked Questions About Depression Treatment in Manhattan
What is treatment-resistant depression?
Treatment-resistant depression (TRD) is generally defined as depression that has not responded adequately to two or more antidepressant treatments at therapeutic doses. It affects a substantial portion of people with major depressive disorder and is one of the most challenging presentations in psychiatry. Ketamine and Spravato were specifically developed and studied with this population in mind. If you’ve tried multiple antidepressants without lasting relief, you may be a strong candidate for what InnerMost offers.
How is ketamine different from antidepressants?
Conventional antidepressants, including SSRIs and SNRIs, work primarily by modulating serotonin or norepinephrine levels in the brain. They typically take four to six weeks to produce results, and they don’t work for a substantial portion of people who try them. Ketamine works through an entirely different mechanism, targeting the brain’s glutamate system and promoting rapid neuroplasticity. It can reduce depressive symptoms within hours to days, and its effects are often noticeable even in people who have not responded to multiple prior medications.
Is Spravato the same as ketamine therapy?
Spravato uses esketamine, a specific form of ketamine delivered as a nasal spray. IV ketamine uses the full ketamine molecule, delivered intravenously. Both work through the glutamate system and can produce rapid antidepressant effects, but they differ in their pharmacological profile, dosing schedule, administration method, and insurance status. Spravato is FDA-approved for treatment-resistant depression and covered by most major insurance plans. IV ketamine is not typically covered. Your InnerMost care team will help you determine which is the better fit for your clinical situation.
How quickly will I feel better?
Many patients notice meaningful improvement in depressive symptoms within hours to days of their first ketamine or Spravato session. That said, individual responses vary, and the durability of relief is strongly influenced by the integration work that follows each session. A full course of treatment, typically six infusion sessions over three to six weeks, is generally recommended before drawing conclusions about long-term response. Your InnerMost team will monitor your progress throughout and adjust your plan as needed.
Do I have to stop my current antidepressants to begin treatment at InnerMost?
Not necessarily. Whether you continue, taper, or pause your current medications depends on your specific situation and will be determined by your InnerMost prescriber during your medical consultation. Some medications interact with ketamine or Spravato and may need to be adjusted. Your clinical team will review your full medication history and guide you through this carefully.
What makes InnerMost different from other depression treatment centers in NYC?
At InnerMost, depression treatment is always delivered within a therapeutic framework. Preparation and integration sessions with a licensed psychotherapist are built into every ketamine and Spravato pathway, not offered as optional extras. We also bring together clinical services, active research trials, and a therapist training hub under one roof, which means the quality of thinking that informs your care is shaped by people at the forefront of the field.
Does InnerMost accept insurance for depression treatment?
Spravato is covered by most major insurance plans, including Aetna, Cigna, UnitedHealthcare, Empire BlueCross, Medicare, and Fidelis. IV ketamine is not typically covered, though some elements of care may be eligible for reimbursement. Psychotherapy coverage varies by plan. Our team will help you verify your benefits and navigate your options.
How do I get to InnerMost from around Manhattan?
Our center is located at 137 East 25th Street, 11th Floor, New York, NY 10010, in the Gramercy neighborhood. We’re easily accessible from Midtown, Flatiron, Gramercy, Chelsea, and the East Village. The 6 train stops at 28th Street, and the N/R/W stops at 28th Street on Broadway, both within walking distance.
What ages does InnerMost treat?
We currently offer depression treatment for adults ages 18 and over.
Ready to Start Your Journey?
If you’re in Manhattan or anywhere in New York City and looking for depression treatment that goes further than what you’ve tried before, we’d love to hear from you. Schedule a free discovery call with an InnerMost care coordinator. It’s a chance to share what you’ve been experiencing, ask questions, and find out whether our approach is the right fit. There’s no obligation and no pressure. We’re here to listen.
Disclaimer: Our clinicians are only licensed to deliver services in-person or via telehealth in the state of New York.
